VC-backed Cydan taps Babar as chief business officer
Cambridge, Massachusetts-based Cydan, an orphan drug accelerator, has named Dr. Imran A. Babar as chief business officer. Previously, Babar worked at OrbiMed Advisors. Cydan's backers include New Enterprise Associates, Pfizer Venture Investments, Lundbeckfonden Ventures, Longitude Capital and Alexandria Venture Investments.
9 April 2018•3 mins read
